BREAKING DOWN THE CREST-2 RANDOMIZED TRIAL RESULTS: MULTIDISCIPLINARY EXPERT INSIGHTS

Thank you to everyone who joined the discussion. Our panel of vascular and regulatory experts explored the latest CREST-2 findings in depth, reviewing results across medical therapy, carotid stenting, and endarterectomy, and examining what these data may signal for TCAR and future clinical decision-making.

Participants

Co-Moderators: Ehrin Armstrong, MD; Raghu Kolluri, MD, MS

Speakers/Panelists: Marc P. Bonaca, MD, MPH; William Herzog, MD; Misty Humphries, MD; D. Christopher Metzger, MD; Parag J. Patel, MD, MS; Gary S. Roubin MD, PhD; Peter A. Schneider, MD

Agenda

CREST-2 Results
Gary S. Roubin MD, PhD

TCAR: Is it Still Relevant?
Peter A. Schneider, MD

What About Optimal Medical Therapy?
Marc P. Bonaca, MD, MPH


Supported in part by